LifeTech Scientific Corporation (1302.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 6.19B |
| Enterprise Value | 5.43B |
| P/E Ratio | 92.38 |
| PEG Ratio | -4.04 |
| Price/Sales Ratio | 4.05 |
| Price/Book Ratio | 1.56 |
| Enterprise/Revenue | 3.32 |
| Enterprise/EBITDA | 15.42 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.05 |
| Operating Margin | 0.1 |
AD
Management Effectiveness
| Return On Assets | 0.01 |
| Return On Equity | 0.02 |
Income Statement
| Revenue | 1.37B |
| Revenue/Share | 0.29 |
| Gross Profit | 1.02B |
| EBITDA | 291.74M |
| Net Income | 147.83M |
| Diluted EPS | 0.03 |
Balance Sheet
| Total Cash | 1.24B |
| Total Cash/Share | 0.28 |
| Total Debt | 14.1M |
| Total Debt/Equity | 0 |
| Current Ratio | 2.45 |
| Book Value Per Share | 0.76 |
Price History
| 52-Week Change | -27.49 |
| 52-Week High | 2.44 |
| 52-Week Low | 1.29 |
| Moving Average 50 Days | 1.41 |
| Moving Average 200 Days | 1.66 |
Statistics
| Average Volume | 17.36M |
| Shares Outstanding | 4.4B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 8:1 |
| Last Split Date | January 12, 2015 |
AD
